| Donna Paige Clement, APN | |
|
58 S Bells St, Alamo, TN 38001-1700 | |
| (731) 696-5401 | |
| Not Available |
| Full Name | Donna Paige Clement |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 31 Years |
| Location | 58 S Bells St, Alamo, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629272620 | NPI | - | NPPES |
| 1507879 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | APN5337 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health Care | Jackson, TN | Home health agency |
| Jackson-madison County General Hospital | Jackson, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Crockett Medical Clinic Inc | 8921009812 | 7 |
News Archive
BioSante Pharmaceuticals, Inc. today announced that development of its GVAX Prostate Cancer Vaccine (GVAX Prostate) for the treatment of prostate cancer has been reinitiated. Manufacturing of new GVAX Prostate is in process, regulatory steps to lift the GVAX Prostate clinical hold prior to trial initiation are being taken, and prostate cancer patients are expected to be treated in a Phase II human clinical trial beginning in the fourth quarter of 2010 at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center.
BBC examines Eritrea's decision to pass on international food aid in an effort to produce enough food for its population. According to Girma Asmerom, Eritrea's ambassador to the EU, "foreign food aid demonises the local people and makes them lazy." The government's strategy for addressing food shortages, includes distributing food from some areas in the country that had a bumper harvest, he said.
Scientists at Albert Einstein College of Medicine of Yeshiva University have made a discovery involving mice and humans that could mean that people with acute myeloid leukemia (AML), a rare and usually fatal cancer, are a step closer to new treatment options. Their study results were published online today in Cancer Cell.
Amgen and its subsidiary, Onyx Pharmaceuticals, Inc., today announced that a planned interim analysis demonstrated that the Phase 3 clinical trial ASPIRE (CArfilzomib, Lenalidomide, and DexamethaSone versus Lenalidomide and Dexamethasone for the treatment of PatIents with Relapsed Multiple MyEloma) met its primary endpoint of progression-free survival (PFS).
› Verified 2 days ago
| Entity Name | Crockett Medical Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104839703 PECOS PAC ID: 8921009812 Enrollment ID: O20070119000217 |
News Archive
BioSante Pharmaceuticals, Inc. today announced that development of its GVAX Prostate Cancer Vaccine (GVAX Prostate) for the treatment of prostate cancer has been reinitiated. Manufacturing of new GVAX Prostate is in process, regulatory steps to lift the GVAX Prostate clinical hold prior to trial initiation are being taken, and prostate cancer patients are expected to be treated in a Phase II human clinical trial beginning in the fourth quarter of 2010 at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center.
BBC examines Eritrea's decision to pass on international food aid in an effort to produce enough food for its population. According to Girma Asmerom, Eritrea's ambassador to the EU, "foreign food aid demonises the local people and makes them lazy." The government's strategy for addressing food shortages, includes distributing food from some areas in the country that had a bumper harvest, he said.
Scientists at Albert Einstein College of Medicine of Yeshiva University have made a discovery involving mice and humans that could mean that people with acute myeloid leukemia (AML), a rare and usually fatal cancer, are a step closer to new treatment options. Their study results were published online today in Cancer Cell.
Amgen and its subsidiary, Onyx Pharmaceuticals, Inc., today announced that a planned interim analysis demonstrated that the Phase 3 clinical trial ASPIRE (CArfilzomib, Lenalidomide, and DexamethaSone versus Lenalidomide and Dexamethasone for the treatment of PatIents with Relapsed Multiple MyEloma) met its primary endpoint of progression-free survival (PFS).
› Verified 2 days ago
| Entity Name | Brownsville Medical Clinic, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659447696 PECOS PAC ID: 0547339772 Enrollment ID: O20080514000503 |
News Archive
BioSante Pharmaceuticals, Inc. today announced that development of its GVAX Prostate Cancer Vaccine (GVAX Prostate) for the treatment of prostate cancer has been reinitiated. Manufacturing of new GVAX Prostate is in process, regulatory steps to lift the GVAX Prostate clinical hold prior to trial initiation are being taken, and prostate cancer patients are expected to be treated in a Phase II human clinical trial beginning in the fourth quarter of 2010 at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center.
BBC examines Eritrea's decision to pass on international food aid in an effort to produce enough food for its population. According to Girma Asmerom, Eritrea's ambassador to the EU, "foreign food aid demonises the local people and makes them lazy." The government's strategy for addressing food shortages, includes distributing food from some areas in the country that had a bumper harvest, he said.
Scientists at Albert Einstein College of Medicine of Yeshiva University have made a discovery involving mice and humans that could mean that people with acute myeloid leukemia (AML), a rare and usually fatal cancer, are a step closer to new treatment options. Their study results were published online today in Cancer Cell.
Amgen and its subsidiary, Onyx Pharmaceuticals, Inc., today announced that a planned interim analysis demonstrated that the Phase 3 clinical trial ASPIRE (CArfilzomib, Lenalidomide, and DexamethaSone versus Lenalidomide and Dexamethasone for the treatment of PatIents with Relapsed Multiple MyEloma) met its primary endpoint of progression-free survival (PFS).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Donna Paige Clement, APN 58 S Bells St, Alamo, TN 38001-1700 Ph: (731) 696-5401 | Donna Paige Clement, APN 58 S Bells St, Alamo, TN 38001-1700 Ph: (731) 696-5401 |
News Archive
BioSante Pharmaceuticals, Inc. today announced that development of its GVAX Prostate Cancer Vaccine (GVAX Prostate) for the treatment of prostate cancer has been reinitiated. Manufacturing of new GVAX Prostate is in process, regulatory steps to lift the GVAX Prostate clinical hold prior to trial initiation are being taken, and prostate cancer patients are expected to be treated in a Phase II human clinical trial beginning in the fourth quarter of 2010 at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center.
BBC examines Eritrea's decision to pass on international food aid in an effort to produce enough food for its population. According to Girma Asmerom, Eritrea's ambassador to the EU, "foreign food aid demonises the local people and makes them lazy." The government's strategy for addressing food shortages, includes distributing food from some areas in the country that had a bumper harvest, he said.
Scientists at Albert Einstein College of Medicine of Yeshiva University have made a discovery involving mice and humans that could mean that people with acute myeloid leukemia (AML), a rare and usually fatal cancer, are a step closer to new treatment options. Their study results were published online today in Cancer Cell.
Amgen and its subsidiary, Onyx Pharmaceuticals, Inc., today announced that a planned interim analysis demonstrated that the Phase 3 clinical trial ASPIRE (CArfilzomib, Lenalidomide, and DexamethaSone versus Lenalidomide and Dexamethasone for the treatment of PatIents with Relapsed Multiple MyEloma) met its primary endpoint of progression-free survival (PFS).
› Verified 2 days ago
Lisa Phillips Ward, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 18 N Cavalier Dr, Alamo, TN 38001 Phone: 731-696-4500 Fax: 731-696-2152 | |
Mrs. Kylie Brown Smith, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 58 S Bells St, Alamo, TN 38001 Phone: 731-696-5401 | |
Mrs. Lori Faye Laman, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 58 S. Bells St., Alamo, TN 38001 Phone: 731-696-5401 Fax: 731-696-5404 | |
Kristin Lea Byrd, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 58 S. Bells St, Alamo, TN 38001 Phone: 731-696-5401 Fax: 731-696-5404 | |
Mrs. Megan Chapman, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 18 N Cavalier Dr., Alamo, TN 38001 Phone: 731-696-4500 Fax: 731-696-2152 | |
Mrs. Elizabeth M Martin, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 18 N Cavalier Dr, Alamo, TN 38001 Phone: 731-696-4500 Fax: 731-696-2152 |